Seeking Alpha

Peregrine Pharmaceuticals (PPHM +1.9%) reverses earlier losses after announcing late Friday it...

Peregrine Pharmaceuticals (PPHM +1.9%) reverses earlier losses after announcing late Friday it had entered into an At Market Issuance Sales Agreement with MLV & Co. to sell up to $75M in stock. The biotech firm also said it issued options to purchase 200K shares each to CEO Steven King and CFO Paul Lytle under the company's stock incentive plan.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|